TING Athlete's Foot Spray Recalled Due to Benzene Contamination
Insight Pharmaceuticals is recalling TING 1% Tolnaftate Athlete's Foot Spray due to benzene contamination. The recall affects approximately 59,644 cans distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall, which requires a minimum severity score of 4 per the rubric. Class I recalls indicate a reasonable probability of serious adverse health consequences. While no illnesses have been reported, the benzene contamination hazard justifies the severe classification.
Plain-English summary
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, is recalling TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid in 4.5 oz (128 g) cans. The recall was initiated due to the presence of benzene, a chemical contaminant.
This is a Class I recall, indicating a potentially serious health risk.
The affected product was distributed nationwide as well as to four foreign locations: Guaynabo, Puerto Rico; Georgetown, Guyana; Baghdad, Iraq; and Accra, Ghana. Approximately 59,644 cans are affected, identified by lot numbers 0H50545 (expiration date 07/31/24) and 1G50645 (expiration date 06/30/25), with UPC 3 63736 81961 3.
Consumers who possess this product should cease using it and consult a healthcare provider regarding any potential exposure.
The recalled product
- Product
- TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid, NET WT 4.5 oz. (128 g) cans, Distributed by: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY 10591 UPC 3 63736 81961 3
- Manufacturer
- Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
- Category
- Drug — Topical Antifungal
- Hazard
- benzene
- chemical-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot # 0H50545
- Exp. date 07/31/24
- 1G50645
- Exp. date 06/30/25
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27